Carisma Therapeutics, Inc. (CARM) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | 1.91M | -5.9M | -10.07M | -8.35M | -13.02M | -16.12M | -22.43M | -16.1M | -21M | -18.55M | -25.53M | -19.55M | -8.32M | -14.3M | 34.6M | -12.6M | -14.66M | -23.14M | -18.48M | -8.51M |
| Operating CF Margin % | 4.22% | - | -269.97% | -228.63% | -384.64% | -175.27% | -660.14% | -375.31% | -548.71% | -520.98% | -787.36% | -523.99% | -322.77% | -529% | 4209.73% | -63% | - | - | -428.65% | - |
| Operating CF Growth % | 114.65% | 63.37% | 55.11% | 48.11% | 38% | 13.09% | 12.18% | 17.66% | -152.36% | -29.71% | -173.79% | -55.16% | 43.25% | 38.21% | 287.3% | -48.08% | -266.37% | -143.9% | -109.04% | 38.36% |
| Net Income | 44.72M | -9.77M | -9.27M | -17.64M | -12.7M | -11.16M | -18.98M | -20.96M | -21.4M | -19.88M | -24.64M | -16.74M | -18.33M | -14.85M | -11.31M | 8.94M | 71.62M | -25.44M | -55.51M | -15.01M |
| Depreciation & Amortization | 0 | 0 | 661K | 669K | 737K | 255K | 1.69M | 722K | 695K | 715K | 705K | 2.01M | 725K | 245K | 218K | 11K | 10K | 34K | 30K | 30K |
| Stock-Based Compensation | 421K | 431K | 508K | 852K | 1.11M | 625K | 1.06M | 873K | 848K | 330K | 265K | 0 | 88K | 58K | 89K | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -288K | 4.83M | 991K | -245K | 963K | 3.13M | 1.66M | 1.18M | 1.26M | 975K | 2.57M | -1.4M | 2.81M | 2.01M | 1.62M | -2.84M | -81.08M | 14.86M | 49.12M | 6.05M |
| Working Capital Changes | -42.94M | -1.4M | -2.96M | 8.01M | -3.13M | -8.97M | -7.86M | 2.09M | -2.4M | -691K | -4.44M | -3.42M | 6.39M | -1.76M | 43.99M | -18.71M | -5.21M | -12.59M | -12.11M | 424K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.47M | -178K | 0 | 0 | -23.39M | 1.2M | 583K | -2.89M | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.14M | 781K | 1.17M | 376K | -328K | -74K | -1.83M | 1.82M | -287K | -2.16M | 2.82M | -2.27M | 1.12M | -1.94M | 2.61M | -1.06M | 2.68M | -777K | -1.1M | 1.58M |
| Cash from Investing | 0 | 163K | 524K | 0 | 0 | -106K | -17K | 10.44M | 29.81M | 35.75M | -3.6M | 13.81M | -2.23M | 20.11M | -64.25M | 0 | 45K | -49K | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -106K | -17K | -561K | -189K | -247K | -135K | -319K | -2.3M | -1.03M | -1.01M | 0 | 45K | -49K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | 1.15% | 0.5% | 13.08% | 4.94% | 6.94% | 4.16% | 8.55% | 89.33% | 38.14% | 122.51% | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 163K | 524K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -1.13M | 0 | -626K | -620K | -461K | 73K | 1.35M | 101K | -2.03M | -3.63M | 67.74M | 992K | -206K | -17K | 35M | 0 | 38.82M | 64.26M | 73.05M | 21.93M |
| Debt Issued (Net) | 60K | 0 | -304K | -271K | -252K | 413K | -1.32M | -150K | -938K | -107K | -106K | -99K | -749K | -17K | 35M | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 5K | -23K | 129K | 0 | 2.29M | 597K | 40K | 52K | 30.64M | 18K | 88K | 0 | 0 | 1K | 38.82M | 64.26M | 73.05M | 21.93M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -1.19M | 0 | -327K | -326K | -338K | -340K | 385K | -346K | -1.14M | -3.58M | 37.21M | 1.07M | 455K | 0 | 0 | -1K | 0 | 0 | 0 | 0 |
| Net Change in Cash | 778K | -5.74M | -10.17M | -8.97M | -13.48M | -16.15M | -21.09M | -5.56M | 6.78M | 13.58M | 38.61M | -46.91M | -983K | 5.79M | 5.35M | -12.6M | 24.2M | 41.07M | 54.58M | 13.42M |
| Free Cash Flow | 1.91M | -5.9M | -10.07M | -8.35M | -13.02M | -16.23M | -22.44M | -16.66M | -21.19M | -18.79M | -25.67M | -19.87M | -10.62M | -15.33M | 33.6M | -12.6M | -14.62M | -23.19M | -18.48M | -8.51M |
| FCF Margin % | 4.22% | - | -269.97% | -228.63% | -384.64% | -176.43% | -660.64% | -388.39% | -553.65% | -527.92% | -791.52% | -532.54% | -412.1% | -567.15% | 4087.23% | -63% | - | - | -428.65% | - |
| FCF Growth % | 114.65% | 63.61% | 55.14% | 49.86% | 38.55% | 13.66% | 12.57% | 16.16% | -99.44% | -22.6% | -176.4% | -57.69% | 27.32% | 33.89% | 281.85% | -48.08% | -265.24% | -144.41% | - | 38.36% |
| FCF per Share | 0.05 | -0.14 | -0.24 | -0.20 | -0.31 | -0.39 | -0.55 | -0.41 | -0.53 | -0.47 | -0.64 | -0.49 | -0.26 | -0.38 | 3.37 | -1.26 | -1.45 | -2.64 | -2.35 | -1.44 |
| FCF Conversion (FCF/Net Income) | 0.04x | 0.60x | 1.09x | 0.47x | 1.03x | 1.44x | 1.18x | 0.77x | 0.98x | 0.93x | 1.04x | 1.17x | 0.45x | 0.96x | -3.06x | -1.41x | 1.43x | 2.54x | 0.33x | 0.57x |
| Interest Paid | 0 | 24K | 0 | 39K | 48K | 55K | 50K | 69K | 0 | 0 | 45K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |